The Latest Breaking News from Moderna

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

Boots and Superdrug have confirmed they are looking at ways to sell Covid vaccines from their high street stores

Dive into the intriguing saga of unanticipated control failures at Moderna's magnate production plant, a juicy scoop exclusively unraveled by the meticulou...

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

The Dow Jones rose to new highs after retail sales beat views while initial unemployment claims came in lower than expected. Moderna soared.

Moderna tests a novel approach to battle skin cancer, with a vaccine showing benefits for melanoma patients. Treatment could be available by 2025.

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. Stocks this morning are mildly higher, with the S&P...

The Dow Jones index reached another high but the market weakened in afternoon trading. CAT stock jumped.

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

The biotech's stock climbs after it reported progress with a skin-cancer vaccine.

Moderna's Merck-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients. Moderna stock soared.